<p>PMGC Holdings Inc. has announced the closing of a secured pre-paid equity purchase, representing its third pre-paid purchase under an existing equity purchase facility. On January 13, 2026, the company received $5 million in gross proceeds from an investor in exchange for common stock, with the transaction including an original issue discount of $464,500. After deducting placement agent fees, PMGC Holdings Inc. obtained net proceeds of $4,562,840. The investor has the right, under certain conditions, to require the company to issue shares at a price equal to 88% of the lowest VWAP over the preceding ten trading days. The agreement includes limitations on ownership percentage and provisions for accelerated repayment in the event of default. Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. PMGC Holdings Inc. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission (Ref. ID: 0001213900-26-005641), on January 20, 2026, and is solely responsible for the information contained therein. © Copyright 2026 - Public Technologies (PUBT) Original Document: here</p>

ELAB

SBIO

<p>PMGC Holdings Inc. has raised $5 million through a secured pre-paid equity purchase, marking its third such transaction. The company received gross proceeds of $5 million, with net proceeds totaling $4,562,840 after fees. The investor can require share issuance at 88% of the lowest VWAP over the last ten trading days, with ownership limitations and accelerated repayment provisions in case of default. This announcement was published via EDGAR on January 20, 2026.</p>

Reuters

iShares Biotechnology ETF

SPDR S&P Biotech

PMGC

Proshares Ultra Nasdaq Biotech

ALPS Medical Breakthrough

First Trust NYSE Arca Biotech Index Fd

VanEck Biotech ETF

Invesco Biotechnology & Genome ETF

PMGC Holdings Raises $5 Million in Private Share Sale